Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Nozza

Showing results (101-110 of 175) with videos related to

Pageof 18
Sort By:
The Journal of Antimicrobial Chemotherapy|September 23, 2025
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohortAlessandra Vergori, Alessandro Cozzi-Lepri, Sergio Lo Caputo, et al.
Journal of Medical Virology|September 27, 2023
HIV-DNA decrease during treatment in primary HIV-1 infection with three different drug regimens: Italian Network of Acute HIV Infection (INACTION) clinical trialElena Bruzzesi, Arianna Gabrieli, Davide Bernasconi, et al.
Plos One|January 12, 2018
HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patientsAnnalisa Saracino, Alessandro Cozzi-Lepri, Milensu Shanyinde, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2025
Question and answers on long-acting therapy with cabotegravir and rilpivirine in people with HIVLucia Taramasso, Stefano Bonora, Antonella Cingolani, et al.
The Journal of Antimicrobial Chemotherapy|February 3, 2012
Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 countsSilvia Nozza, Filippo Canducci, Laura Galli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 15, 2017
Role of Normalized T-Cell Subsets in Predicting Comorbidities in a Large Cohort of Geriatric HIV-Infected PatientsAndrea Calcagno, Stefania Piconi, Emanuele Focà, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 16, 2022
Prevalence and Risk Factors of Anal HPV Infection in MSM Living With HIV: Identifying the Target Groups to Prioritize for ImmunizationElena Bruzzesi, Laura Galli, Andrea Poli, et al.
HIV Medicine|December 1, 2025
User-reported outcomes of long-acting injectable PrEP with Cabotegravir: Real-world experience from MilanAngelo Roberto Raccagni, Flavia Passini, Riccardo Lolatto, et al.
AIDS Research and Human Retroviruses|September 13, 2022
Perceptions of U = U Among Italian Infectious Diseases Specialists: A Nationwide Survey on Providers' Attitudes Toward the Risk of HIV Transmission in Virologically Suppressed PatientsDiego Ripamonti, Mariacristina Poliseno, Giovanni Mazzola, et al.
The New Microbiologica|December 20, 2022
Preferences of PLWH and of clinicians for HIV treatment aimed at long-term successMassimo Andreoni, Andrea Antinori, Antonella Castagna, et al.
Pageof 18

Showing results (101-110 of 175) with videos related to

Sort By:
Pageof 18
The Journal of Antimicrobial Chemotherapy|September 23, 2025
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohortAlessandra Vergori, Alessandro Cozzi-Lepri, Sergio Lo Caputo, et al.
Journal of Medical Virology|September 27, 2023
HIV-DNA decrease during treatment in primary HIV-1 infection with three different drug regimens: Italian Network of Acute HIV Infection (INACTION) clinical trialElena Bruzzesi, Arianna Gabrieli, Davide Bernasconi, et al.
Plos One|January 12, 2018
HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patientsAnnalisa Saracino, Alessandro Cozzi-Lepri, Milensu Shanyinde, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2025
Question and answers on long-acting therapy with cabotegravir and rilpivirine in people with HIVLucia Taramasso, Stefano Bonora, Antonella Cingolani, et al.
The Journal of Antimicrobial Chemotherapy|February 3, 2012
Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 countsSilvia Nozza, Filippo Canducci, Laura Galli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 15, 2017
Role of Normalized T-Cell Subsets in Predicting Comorbidities in a Large Cohort of Geriatric HIV-Infected PatientsAndrea Calcagno, Stefania Piconi, Emanuele Focà, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 16, 2022
Prevalence and Risk Factors of Anal HPV Infection in MSM Living With HIV: Identifying the Target Groups to Prioritize for ImmunizationElena Bruzzesi, Laura Galli, Andrea Poli, et al.
HIV Medicine|December 1, 2025
User-reported outcomes of long-acting injectable PrEP with Cabotegravir: Real-world experience from MilanAngelo Roberto Raccagni, Flavia Passini, Riccardo Lolatto, et al.
AIDS Research and Human Retroviruses|September 13, 2022
Perceptions of U = U Among Italian Infectious Diseases Specialists: A Nationwide Survey on Providers' Attitudes Toward the Risk of HIV Transmission in Virologically Suppressed PatientsDiego Ripamonti, Mariacristina Poliseno, Giovanni Mazzola, et al.
The New Microbiologica|December 20, 2022
Preferences of PLWH and of clinicians for HIV treatment aimed at long-term successMassimo Andreoni, Andrea Antinori, Antonella Castagna, et al.
Pageof 18